---
title: "Ambrx Biopharma (AMAM.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AMAM.US/norm.md"
symbol: "AMAM.US"
name: "Ambrx Biopharma"
parent: "https://longbridge.com/en/quote/AMAM.US.md"
datetime: "2026-05-21T22:28:50.478Z"
locales:
  - [en](https://longbridge.com/en/quote/AMAM.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AMAM.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AMAM.US/norm.md)
---

# Ambrx Biopharma (AMAM.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3693 | -0.0456 | -0.0486 | -0.4031 | -0.1068 |
| ROE | - | - | - | - | - |
| Revenue | 53000.00 | 1.12M | 24000.00 | 1.60M | 1.30M |
| Net income | -22.99M | -17.83M | -15.30M | -15.57M | -28.84M |

## Balance Sheet (USD)

| Indicator | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
| --- | --- | --- | --- | --- | --- |
| A&L | 271.50M | 279.94M | 210.61M | - | 180.87M |
| Leverage | 1.12 | 1.12 | 1.15 | - | 1.27 |
| BVPS | 3.85 | 0.5793 | 0.4724 | - | 0.5249 |
| Turnover | - | 0.0245 | - | - | 0.0265 |

## Cash Flow Statement (USD)

| Indicator | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -18.88M | -13.15M | -12.97M | -15.78M | -14.53M |
| Investing CF | 6.16M | 9.18M | 29.55M | -252000.00 | -63.43M |
| Financing CF | 9.71M | 82.65M | 77.22M | 1.47M | -28000.00 |
| Free CF | -13.32M | -8.39M | - | - | - |